Of course, in vivo administration of MTK in SOD1G93A mice may provide beneficial effects not only by acting on GPR17-expressing OPCs, but also by managing other pathological features of ALS, including oxidative stress and neuroinflammation, as already described for different disease models [30]. Here, GPR17 is linked to amyotrophic lateral sclerosis.